In order to investigate whether NRP1 expression is associated with 5-year survival of patients with melanoma at specific stages of the disease, the patient cohort was divided into those with primary melanoma and those with metastatic melanoma, and patient survival in each group was analyzed. Here, NRP1 is linked to melanoma.